Clinical Trial Update: Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cord blood with T-cell depleted haplo-identical peripheral blood stem cell transplantation for hematologic malignancies has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Myelodysplastic Syndrome

Drugs mentioned

• Cord blood with T-cell depleted haplo-identical peripheral blood stem cell transplantation

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-08-05